Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Denali Therapeutics Inc.

Clinical trials sponsored by Denali Therapeutics Inc., explained in plain language.

Denali Therapeutics Inc. DNLI NASDAQ

A biopharmaceutical company developing therapies for neurodegenerative diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 4

Can a new drug tame Alzheimer's? early trial aims to find out

Disease control Not yet recruiting

This early-stage trial is testing an experimental drug called DNL921 to see if it is safe and tolerable for people. It will involve healthy volunteers and people with Alzheimer's disease, who will receive either the drug or a placebo. The main goal is to gather safety data and un…

Phase: PHASE1 • Sponsor: Denali Therapeutics Inc. • Aim: Disease control

Last updated Aug 13, 2026 00:00 UTC